Geiger Counter Ltd - Release of Interim Report and Financial Statements
![]() |
Geiger Counter Limited Plc
(the "Company")
RELEASE OF INTERIM REPORT AND FINANCIAL STATEMENTS
The Directors announce the release of the Interim Report and Financial Statements for the period ended
http://www.rns-pdf.londonstockexchange.com/rns/4061K_1-2026-6-30.pdf
CHAIRMAN'S STATEMENT - FOR THE PERIOD ENDED
Introduction
I should firstly advise Shareholders that Mr
This has been a busy period for the Company; the uranium market has continued its recovery during the six months under review and the net asset value ("NAV") per ordinary share of the Company as at
The Company also advised on
Market and Performance
The uranium spot price was volatile during the six-month period under review; having started the period at
The Board continues to be excited by the fundamentals for nuclear energy and uranium markets and believes that the Company is very well placed to benefit from these.
Share Buybacks and Subscription Rights
The Company has continued to engage in a program of stock buybacks to provide liquidity, increase the NAV per ordinary share and ideally narrow the discount. During the period under review the Board has utilised its share buyback powers to repurchase 8,144,747 ordinary shares at a cost of
The Annual Subscription Right enables Shareholders to subscribe for 1 new Ordinary Share for every 5 Ordinary Shares held on 30 April in each year at a price equal to the undiluted NAV per ordinary share on 1 May one year prior. The Company announced on
Following the end of the period under review the Company has announced that following the exercise of all Subscription Rights, the Company has raised a total of
Portfolio Management
After being advised that the Company's two co-portfolio managers,
In order to ensure that portfolio management services remained available to the Company, on
Effective from
The Company considers this action to be in the best interests of shareholders as the Company continues to explore its options for the long term. A further update will be provided in due course.
The Board
Further to the announcement on
Outlook
The outlook for the uranium market remains very positive with global AI and data centre power requirements giving a strong emphasis to the stable base load characteristics of nuclear power. Thirty-eight countries have committed to tripling nuclear energy capacity by 2050. Your investment managers and Board of Directors believe that the fundamental structural support for uranium equities remains as strong as ever, and that with growing global nuclear power demand coupled with a highly constrained and fragile supply landscape, our portfolio is well-positioned to benefit.
On behalf of the Board, I would like to thank shareholders for their continued support in the Company.
Chairman
INVESTMENT ADVISER'S REPORT - FOR THE PERIOD ENDED
A strong first half
During the interim period the uranium market strengthened considerably as structural supply deficits, production disruptions, increasing utility contracting, financial buying, and enthusiasm for nuclear power converged to support higher prices. Against this backdrop the uranium market experienced a renewed phase of positive momentum from
Opportunistic purchasing by physically backed ETFs, most notably the Sprott Physical Uranium Trust, coincided with some further modest buying activity by Cameco to offset production shortfalls, with the combined effect helping boost the uranium price. Having started the period at
The performance of uranium equities broadly mirrored the improved fundamentals and the Fund NAV ended the half year at 87.6p, a healthy gain of nearly 21%, despite retracing from its late-January high of over 107p. This compared favourably to the half year sterling returns of 9.9% and 2% registered by the Sprott Uranium Miners ETF and the Solactive Pure Play Uranium Index respectively. The most significant contributions to Fund performance were made by Nexgen, Paladin and Denison Mines whose share prices rose over 30%-40% in sterling terms. Developers Nexgen and Denison both received authorisation to commence development, the final approval required, from the Canadian Nuclear Safety Commission in the March quarter. Paladin Energy benefited from the restart of the Langer Heinrich mine and from improving investor confidence in near-term uranium production growth. The Company represented one of the few meaningful uranium restart stories capable of delivering additional supply in the medium term.
Supply-Demand Imbalance Intensifies
The principal driver of uranium prices during the review period was the growing recognition that the uranium market remained in structural deficit. Global uranium supply continued to lag projected reactor demand, while secondary supplies and inventories were increasingly viewed as insufficient to bridge the gap over the medium term.
On the supply side Cameco lowered production guidance (from 18Mlbs to 14-15Mlbs) at its
Nevertheless, the reduction in licensing prompted a focus of attention on the longer-term outlook for regional supply and reinforced the group's value over volume strategy.
Against this demand expectations strengthened considerably. Of note, having renewed its funding capability SPUT acquired around 8Mlbs of uranium over the interim period. This coincided with purchases by Cameco which acquired 3.1M lbs U3O8 during the six months to end March alongside which it procured 2.75Mlbs under product loan agreements and utilised 0.9Mlbs of inventory to make good on its reduced output.
Nuclear power integral to international energy policies
More broadly, governments across
The World Nuclear Association's forecasts for reactor requirements projected uranium demand more than doubling by 2040. Utilities responded by accelerating long-term contracting discussions after remaining relatively under-contracted for several years. This contracting cycle became a major pillar supporting the long-term uranium price. Utilities responded by accelerating long-term contracting discussions after remaining relatively under-contracted for several years. Global nuclear fuel requirements continue to exceed primary mining production by roughly 40-50Mlbs annually.
Uranium Contracting
With supply deficit conditions forecast to widen, contracting has become a key pillar supporting the long-term uranium price. While reports describe 2025 as a period where utilities, having exhausted stockpiles and relying on spot purchases during 2020-2022, aggressively re-entered the term market. Despite the improving contract volumes estimated at around 120Mlbs in 2025 (of which 72Mlbs took place in calendar Q4), the annual contracting volume remained below the estimated replacement rate of ~150Mlbs pa. With the exception of
Outlook and positioning
The uranium mining sector remains one of the strongest performing commodity themes globally, supported by a combination of structural energy transition dynamics and ongoing physically backed investor participation. The sector is also a direct beneficiary of energy focussed geopolitics, though as Western governments enact plans to reduce their reliance on Russian enrichment the widening supply deficit is increasingly the more relevant consideration for investors.
Despite recently taking some profits in Nexgen, following its strong performance into its final permit award, the Company remains weighted to developers and Nexgen remains the largest holding. This is to give full participation into future uranium price gains; where the likes of Cameco are largely contracted out for the next 5 years with a degree of fixed pricing, and as a result will not see the full benefit of a stronger priced uranium market. Positioning remains focused on names that will benefit from stronger uranium pricing, and the anticipated upcoming increase in western reactor contracting. We believe these names offer the greatest return through the cycle as they are strategically the most significant for gaining both political and regulatory support.
Top 5 Holdings
Nexgen
• Key catalyst: Federal Permit approved in
• Largest high-grade deposit globally in tier 1 Canadian Athabasca basin.
• Uncontracted so has full participation in uranium price upside.
• Scarcity premium for a Tier 1 asset.
Ur-Energy
• Largest US producer.
• Attractive valuation versus better marketed US peers.
• High spot uranium participation.
• Future beneficiary of supportive regulatory backdrop in the US as they need more uranium.
Paladin Energy
• Mostly spot price exposed - well placed for western reactor contracting.
• Producer in
• Strong operational turnaround has seen production increase.
Cameco
• The Company is underweight Cameco because it is heavily contracted and therefore will have not have full participation in uranium price upside.
• Whilst richer in valuation, Cameco remains the go to big liquid name in the sector.
• Owns 49% of Westinghouse, with its leading AP-1000 reactor design is well placed to benefit from nuclear construction renaissance.
• Benefitting from strong uranium conversion pricing via exposure in Westinghouse.
Denison Mines
• Canadian uranium explorer and developer.
• Flagship asset is the
• Strong diverse array of strategic assets including physical uranium holdings.
CQS (UK) LLP
Enquiries
|
Manulife | CQS |
|
T: +44 (0) 20 7201 5368
|
|
Cavendish Capital Markets Limited |
Tunga Chigovanyika (Corporate Finance)
|
T: +44 (0) 20 7397 1915
|
|
|
|
T: +44 (0) 20 7220 0500 |
|
Summit Fund Services Jersey Limited |
|
T :+44 (0) 1534 825 259 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE